Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
BRL 8.71
(-3.11%)
BRL 8.71
(-3.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 255.09 Million | 205.48 Million | 131.85 Million | 130.98 Million | 128.79 Million | 109.88 Million |
| Net Income | 92.9 Million | 86.34 Million | 79.42 Million | 56.15 Million | 76.75 Million | 74.98 Million |
| Depreciation & Amortization | 200.15 Million | 184.56 Million | 157.77 Million | 117.77 Million | 95.33 Million | 28.12 Million |
| Deferred income taxes | -4.28 Million | -12.2 Million | -5.01 Million | -11.64 Million | -10.26 Million | 1.21 Million |
| Stock-based compensation | 5.61 Million | 4.5 Million | 2.67 Million | 611 Thousand | - | - |
| Change in working capital | -68.39 Million | -104.23 Million | -108.42 Million | -73.53 Million | -66.03 Million | -8.34 Million |
| Other non-cash items | 460.31 Million | 38.8 Million | 3.08 Million | 30.58 Million | 22.73 Million | 15.11 Million |
| Investing Cash Flow | -196.55 Million | -131.08 Million | 14.9 Million | -390.49 Million | -53.87 Million | -58.94 Million |
| Investments in PPE | -139.44 Million | -181.63 Million | -135.58 Million | -84.79 Million | -53.87 Million | -58.94 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -57.11 Million | - | - | -305.7 Million | - | - |
| Sales/Maturities of investments | - | 39.07 Million | 150.48 Million | - | - | - |
| Other Investing Activities | -82.13 Million | 11.47 Million | 124.95 Million | -326.61 Million | -14.34 Million | -9.59 Million |
| Financing Cash Flow | -56.29 Million | -103.11 Million | -222.43 Million | 318.18 Million | -42.63 Million | -70.58 Million |
| Debt repayment | -137.16 Million | -52.85 Million | -59.12 Million | -110.26 Million | -152.73 Million | -43.49 Million |
| Dividends payments | -28.72 Million | -24.75 Million | -20.44 Million | -18.24 Million | -20.78 Million | -17.89 Million |
| Common Stock Repurchased | -715 Thousand | -1.6 Million | -20.4 Million | -18.76 Million | - | -14.32 Million |
| Common Stock Issuance | 2.07 Million | 1.44 Million | 683 Thousand | 459.09 Million | - | - |
| Other Financing Activities | -166.1 Million | -25.34 Million | -123.14 Million | 6.36 Million | 130.89 Million | -9.19 Million |
| Accounts receivables | -46.59 Million | -64.8 Million | -37.59 Million | -18.29 Million | -64.08 Million | 4.95 Million |
| Accounts payables | 124.31 Million | 89.03 Million | 90.45 Million | 68.6 Million | 23.38 Million | 17.23 Million |
| Inventory | -103.01 Million | -157.64 Million | -164.45 Million | -145.8 Million | -55.64 Million | -25.73 Million |
| Other working capital | -43.1 Million | 29.17 Million | 3.17 Million | 21.95 Million | 30.31 Million | 17.38 Million |
| Cash at beginning of period | 25.71 Million | 54.43 Million | 130.1 Million | 71.43 Million | 39.14 Million | 58.79 Million |
| Cash at end of period | 27.95 Million | 25.71 Million | 54.43 Million | 130.1 Million | 71.43 Million | 39.14 Million |
| Capital Expenditure | -139.44 Million | -181.63 Million | -135.58 Million | -84.79 Million | -53.87 Million | -58.94 Million |
| Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
| Net cash flow / Change in cash | 2.23 Million | -28.72 Million | -75.67 Million | 58.67 Million | 32.29 Million | -19.65 Million |
| Free Cash Flow | 115.65 Million | 23.84 Million | -3.72 Million | 46.18 Million | 74.92 Million | 50.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.13 Million | 33.54 Million | 92.9 Million | 29.01 Million | 23.64 Million | 22.03 Million |
| Depreciation & Amortization | 51.74 Million | 51.47 Million | 200.15 Million | 50.69 Million | 50.06 Million | 49.78 Million |
| Deferred income taxes | -14.58 Million | 6.67 Million | -4.28 Million | -5.45 Million | -1.29 Million | -5.21 Million |
| Stock-based compensation | 1.41 Million | 1.45 Million | 5.61 Million | 1.33 Million | 1.47 Million | 1.65 Million |
| Change in working capital | 25.06 Million | -100.06 Million | -68.39 Million | 27.65 Million | -13.62 Million | 3.68 Million |
| Other non-cash items | 142.51 Million | 211.71 Million | 460.31 Million | 28.14 Million | 17.37 Million | 20.63 Million |
| Investing Cash Flow | -34.8 Million | -41.03 Million | -196.55 Million | -3.13 Million | -93.75 Million | 35.6 Million |
| Investments in PPE | -29.17 Million | -24.72 Million | -139.44 Million | -41.61 Million | -36.01 Million | -32.5 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -5.62 Million | -16.3 Million | -57.11 Million | 38.48 Million | -57.73 Million | 68.11 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -8.49 Million | -24.6 Million | -82.13 Million | 31.59 Million | -64.29 Million | 62.78 Million |
| Financing Cash Flow | -64.16 Million | 35.28 Million | -56.29 Million | -69.86 Million | 19.42 Million | -130.28 Million |
| Debt repayment | -6.49 Million | -90 Million | -137.16 Million | -27.38 Million | -204.03 Million | -56.41 Million |
| Dividends payments | -15.31 Million | -10.64 Million | -28.72 Million | -290 Thousand | -7.23 Million | -13.64 Million |
| Common Stock Repurchased | - | - | -715 Thousand | - | -10 Thousand | 54.34 Million |
| Common Stock Issuance | 1.88 Million | - | 2.07 Million | - | - | 2.07 Million |
| Other Financing Activities | -44.23 Million | - | -166.1 Million | -42.77 Million | 230.7 Million | -116.63 Million |
| Accounts receivables | 90.34 Million | -32.61 Million | -46.59 Million | -41.75 Million | -29.9 Million | 15.45 Million |
| Accounts payables | -130.6 Million | 10.27 Million | 124.31 Million | 167.16 Million | 45.79 Million | 10.68 Million |
| Inventory | 27.41 Million | -78.13 Million | -103.01 Million | -68.7 Million | -22.64 Million | -34.15 Million |
| Other working capital | 37.91 Million | 419 Thousand | -43.1 Million | -29.04 Million | -6.86 Million | 11.69 Million |
| Cash at beginning of period | 22.12 Million | 27.95 Million | 25.71 Million | 15.57 Million | 12.27 Million | 14.36 Million |
| Cash at end of period | 16.7 Million | 22.12 Million | 27.95 Million | 27.95 Million | 15.57 Million | 12.27 Million |
| Capital Expenditure | -29.17 Million | -24.72 Million | -139.44 Million | -41.61 Million | -36.01 Million | -32.5 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.42 Million | -5.82 Million | 2.23 Million | 12.37 Million | 3.3 Million | -2.09 Million |
| Free Cash Flow | 64.36 Million | -24.79 Million | 115.65 Million | 43.75 Million | 41.61 Million | 60.07 Million |
2022
DXLG
CMCO
0606
009310
2012